Main menu

NEW YORK (GenomeWeb News) – Multiplicom has raised €5.5 million ($7.3 million) to support further development of its molecular diagnostic tests and expansion of its business.

Flemish investment firm PMV, RMM (Rudi Mariën) and Qbic ARKIV Fund were new investors in the round. Existing investors including Belgian venture capital firm Gimv, Gimv-managed Biotechfonds Vlaanderen, and life science research institute VIB continue to support Multiplicom, it said, adding VIB will make an investment in kind.